ATE338061T1 - Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen - Google Patents

Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen

Info

Publication number
ATE338061T1
ATE338061T1 AT00950358T AT00950358T ATE338061T1 AT E338061 T1 ATE338061 T1 AT E338061T1 AT 00950358 T AT00950358 T AT 00950358T AT 00950358 T AT00950358 T AT 00950358T AT E338061 T1 ATE338061 T1 AT E338061T1
Authority
AT
Austria
Prior art keywords
hav
hepatitis
virus
synthetic peptides
peptides
Prior art date
Application number
AT00950358T
Other languages
English (en)
Inventor
Howard A Fields
Yury E Khudyakov
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE338061T1 publication Critical patent/ATE338061T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G01N2333/10—Hepatitis A virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00950358T 1999-07-15 2000-07-14 Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen ATE338061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14441299P 1999-07-15 1999-07-15

Publications (1)

Publication Number Publication Date
ATE338061T1 true ATE338061T1 (de) 2006-09-15

Family

ID=22508471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00950358T ATE338061T1 (de) 1999-07-15 2000-07-14 Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen

Country Status (6)

Country Link
EP (1) EP1200464B1 (de)
AT (1) ATE338061T1 (de)
AU (1) AU775557B2 (de)
CA (1) CA2378924A1 (de)
DE (1) DE60030443T2 (de)
WO (1) WO2001005824A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23553A1 (es) * 2004-12-06 2010-07-20 Univ Glasgow Div Immunology Péptidos que mimetizan las regiones antigénicas del virus de la hepatitis a
EP2680879B1 (de) * 2011-03-04 2021-01-06 Shire Human Genetic Therapies, Inc. Peptidlinker für polypeptidzusammensetzungen und anwendungsverfahren dafür

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3048689A (en) * 1988-01-13 1989-08-11 University Of North Carolina At Chapel Hill, The Immunogenic peptides
WO1997040147A1 (en) * 1996-04-19 1997-10-30 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Antigenically reactive regions of the hepatitis a virus polyprotein

Also Published As

Publication number Publication date
CA2378924A1 (en) 2001-01-25
EP1200464A2 (de) 2002-05-02
WO2001005824A2 (en) 2001-01-25
DE60030443T2 (de) 2007-08-23
DE60030443D1 (de) 2006-10-12
AU6347200A (en) 2001-02-05
AU775557B2 (en) 2004-08-05
EP1200464B1 (de) 2006-08-30
WO2001005824A3 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
ATE185350T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
Francis et al. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides
RU2004136165A (ru) Способ одновременного обнаружения антигенов и антител против инфекционного микроорганизма
ATE125821T1 (de) Vakzin gegen hepatitis b.
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
KR940703851A (ko) E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies)
CN106093402A (zh) 丙型肝炎病毒抗原抗体联合检测试剂盒
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
DE60113139D1 (de) Hcv mosaik antigen zusammensetzung
DK157186A (da) Ekspression af immunologisk aktive virale proteiner
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
DE60030443D1 (de) Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen
Parry et al. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles
KR930703445A (ko) 톡소플라스마 곤디(toxoplasma gondii)의 단백질 항원의 클로닝 및 발현
US5885771A (en) Antigenic peptide compound and immunoassay
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
DE69830174D1 (de) Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene
Sallberg et al. The Antigen/Antibody Specificity Exchanger: A New Peptide-Based Tool for Re-directing Antibodies of Other Specificities to Recognize the V3 Domain of HIV-1 GP120
JPS6490197A (en) Peptide
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200464

Country of ref document: EP

REN Ceased due to non-payment of the annual fee